← Back to Clinical Trials
Recruiting NCT05368571

NCT05368571 CHOICES-TEEN Randomized Controlled Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05368571
Status Recruiting
Phase
Sponsor University of Texas at Austin
Condition Risk for an Alcohol-Exposed Pregnancy
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2022-04-08
Primary Completion 2026-04-10

Eligibility & Interventions

Sex Female only
Min Age 14 Years
Max Age 19 Years
Study Type INTERVENTIONAL
Interventions
CHOICES-TEENHealth and Life Skills Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2022-04-08 with a primary completion date of 2026-04-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial will: 1) Test the efficacy of the CHOICES-TEEN (CT) intervention compared with an Attentional Control (AC) condition on reducing the risk of substance-exposed pregnancy (SEP) and HIV/STI among high-risk female youth involved with the juvenile justice system by reducing alcohol use, increasing marijuana cessation, reducing risk of pregnancy, and increasing condom use; 2) Test the efficacy of CT, compared to AC, on increasing cognitive self-regulation abilities; 3) Test proposed intervention mediators/mechanisms of action for CT overall and by race/ethnicity; and 4) Test the moderating effect of initial readiness to change on risk of SEP and risk of HIV/STI.

Eligibility Criteria

Inclusion Criteria: Female adolescents between 14-19 years of age, of any race, who are at risk of substance-exposed pregnancy and HIV/STI will be eligible. Specifically, they must report the following behaviors within the last 3 months: * sexual intercourse with a male * inconsistent/ineffective condom use AND * inconsistent/ineffective contraception use Exclusion Criteria: * severe cognitive and/or psychiatric impairment that precludes cooperation with study protocol, per judgement of the interventionist or research staff * do not speak or read/write in English * unable to meet study requirements, including follow-up assessments

Contact & Investigator

Central Contact

Danielle E Parrish, Ph.D.

✉ danielle_parrish@baylor.edu

📞 346-701-8047

Principal Investigator

Danielle E Parrish, Ph.D.

PRINCIPAL INVESTIGATOR

Baylor University

Frequently Asked Questions

Who can join the NCT05368571 clinical trial?

This trial is open to female participants only, aged 14 Years or older, up to 19 Years, studying Risk for an Alcohol-Exposed Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05368571 currently recruiting?

Yes, NCT05368571 is actively recruiting participants. Contact the research team at danielle_parrish@baylor.edu for enrollment information.

Where is the NCT05368571 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT05368571 clinical trial?

NCT05368571 is sponsored by University of Texas at Austin. The principal investigator is Danielle E Parrish, Ph.D. at Baylor University. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology